Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 18, 2013 - Issue 2
Submit an article Journal homepage
138
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

Sheila Raghavan *Gynuity Health Projects, New York, USACorrespondence[email protected]
,
Tamar TsereteliGynuity Health Projects, Tbilisi, Georgia
,
Asamidin KamilovMinistry of Health, Uzbekistan
,
Dilfuza KurbanbekovaWomen's Wellness Center, Tashkent, Uzbekistan
,
Dilmurod YusupovWomen's Wellness Center, Tashkent, Uzbekistan
,
Feruza KasimovaClinic #2 of Tashkent Medical Academy, Tashkent, Uzbekistan
,
Dilbar JymagylovaMunicipal Maternity House #10, Tashkent, Uzbekistan
&
Beverly Winikoff *Gynuity Health Projects, New York, USA
 show all
Pages 104-111 | Published online: 07 Feb 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Karmen S. Louie, Tamar Tsereteli, Erica Chong, Faiza Aliyeva, Gulnara Rzayeva & Beverly Winikoff. (2014) Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan. The European Journal of Contraception & Reproductive Health Care 19:6, pages 457-464.
Read now
Patricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, María Laura García Martinez, Ana Gabriela Aranguré Peraza, Manuel Bousiéguez, Tara Shochet & Beverly Winikoff. (2014) Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City. Reproductive Health Matters 22:sup44, pages 75-82.
Read now

Articles from other publishers (11)

Jill M. Hagey, Matthew Givens & Amy G. Bryant. (2022) Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology. Obstetrical & Gynecological Survey 77:10, pages 611-623.
Crossref
. (2020) Medication Abortion Up to 70 Days of Gestation. Obstetrics & Gynecology 136:4, pages e31-e47.
Crossref
. (2020) Medication Abortion Up to 70 Days of Gestation. Contraception 102:4, pages 225-236.
Crossref
Bushra Alam, Amy Kaler & Zubia Mumtaz. (2020) Women’s voices and medical abortions: A review of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology 249, pages 21-31.
Crossref
Katherine Gambir, Caron Kim, Kelly Ann Necastro, Bela Ganatra & Thoai D Ngo. (2020) Self-administered versus provider-administered medical abortion. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Claire TebbetsDiana SantanaJosé Ros SilvestreDee Redwine. (2018) Building Bridges: A Case for Community Health Worker Provision of Misoprostol-Only Abortion in the First Trimester. Journal of Women's Health 27:3, pages 311-316.
Crossref
Ingrida Platais, Tamar Tsereteli, Rodica Comendant, Dilfuza Kurbanbekova & Beverly Winikoff. (2015) Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan. Contraception 91:2, pages 178-183.
Crossref
Friday Okonofua, Oladapo Shittu, Tara Shochet, Ayisha Diop & Beverly Winikoff. (2014) Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria. International Journal of Gynecology & Obstetrics 125:1, pages 49-52.
Crossref
. (2014) Practice Bulletin No. 143. Obstetrics & Gynecology 123:3, pages 676-692.
Crossref
. (2014) Medical management of first-trimester abortion. Contraception 89:3, pages 148-161.
Crossref
Rebecca Gomperts, Kirsten van der Vleuten, Kinga Jelinska, Cecilia Veiera da Costa, Kristina Gemzell-Danielsson & Gunilla Kleiverda. (2014) Provision of medical abortion using telemedicine in Brazil. Contraception 89:2, pages 129-133.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.